Jacob shares his story of benzodiazepine harm and healing in a rap for our #BenzoStories series. #BenzoStories is a series by our nonprofit, Benzodiazepine Information Coalition, sharing powerful stories of patient harm associated with prescribed…
Duke University’s Margolis Center for Health Policy, in cooperation with the FDA, held a public workshop Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives on July 12 and 13. Our director, Dr. Christy Huff,…
Sonja Styblo from our general advisory board talks about the importance of language and why the term cold turkey can be problematic. Why is the term “cold turkey” confusing to prescribers and outsiders? As noted…
Please join us in welcoming Dr. Josef Witt-Doerring back to our medical advisory board. Dr. Witt-Doerring is a board-certified psychiatrist running a private practice specializing in helping patients safely discontinue psychiatric medications. Dr. Witt-Doerring’s interest…
Please join us in welcoming Dr. Harold Gottlieb to our medical advisory board. Dr. Gottlieb has served as a Chief Medical Officer for many years. He was the Gulf Coast Regional Chief Medical Officer for CHRISTUS…
We have released an updated version of our benzodiazepine informed consent. Authored by Dr. Christy Huff at Benzodiazepine Information Coalition and Dr. Steven Wright at the Alliance for Benzodiazepine Best Practices, the consent form is…
Dr. Christy Huff presented Safe Prescribing Protocols of Benzodiazepines: Lessons Learned from the Opioid Crisis alongside Dr. Alexis Ritvo on July 18, 2021. [pdf id=17349]
In 2017 we started our MedWatch Reporting Program. This ongoing program gives patients information to report their own benzodiazepine experiences to the FDA. So far it has been a success. In September, 2020, the FDA…
